GlobalData
GlobalData

Tamika Providence

  • Home
  • Author: Tamika Providence

Portugal’s general insurance industry to reach €6.7bn in 2025

Portugal’s general insurance industry is projected to grow from €5.28bn (US$6.03bn) in 2020 to €6.68bn (US$8.35bn) in 2025 in terms of gross written premiums (GWP), according to GlobalData, a leading data and analytics company. As per the latest data from GlobalData, the general insurance industry in Portugal is projected to grow at a compound annual […]
Read more

Global food security must be part of the COP26 conversation

Food security is a vital factor to consider in the climate crisis narrative, and one that should be prioritised during the COP26 summit, says GlobalData. The leading data and analytics company notes that, following UN General Secretary António Guterres’ opening speech on how extreme weather is unproportionally impacting many developing nations, it is imperative that […]
Read more

The ‘climatarian’ marks next dietary trend in wake of COP26

The ‘climatarian’ diet, which is built upon reduced meat consumption, and, ideally, the adoption of a plant-based diet, has gained increasing attention as global warming continues to dominate the headlines. Research from GlobalData, a leading data and analytics company, reveals that the global plant-based meat alternatives sector grew at a compound annual growth rate (CAGR) […]
Read more

Space Perspective planning to offer world’s first luxury spaceflight experience as ‘space balloon tourism’ is set to take off

Virgin Galactic and Blue Origin have made sub-orbital space travel a reality for those travel adventurers and space explorers with the desire and disposable income to pay up to $450,000 for a ticket. Both of these companies have demonstrated that space tourism is a potentially massive market and, whilst not without risk, can be accomplished […]
Read more

McDonald’s ‘three D’s’ strategy helped it beat Q3 sales estimates

Following today’s news that McDonald’s has reportedly beaten its Q3 sales estimates; Carmen Bryan, Consumer Analyst at GlobalData, a leading data and analytics company, offers her view: “McDonald’s has demonstrated a winning strategy during this challenging period. By focusing on digital, delivery and drive-thru – neatly dubbed as the ‘three D’s’ – the company has […]
Read more

Thermal power to comprise 46.1% of Czech Republic energy mix by 2030 making the transition to renewable power and it’s GHG emissions targets difficult to achieve

The Czech Republic has ambitious plans to phase out coal and transition to more renewable power by 2030, however the country seems to have no clear roadmap to achieve this goal. Thermal power holds a significant share in the country’s current generation mix and is still expected to comprise 46.1% of total power generation by […]
Read more

Creation of mobile health program offers hope to the 16.1% of US population expected to be diagnosed with Parkinson’s disease by 2030

Mobile health applications have been increasingly popular since the beginning of the COVID-19 pandemic helping patients stay up-to-date on their health remotely, while also ensuring that healthcare organizations are not overstretched. A number of applications have gained popularity over this period in various parts of the healthcare field, such as the use of video applications […]
Read more

Airbus investment shows diversity of growing ESG market

Following recent news that Airbus has completed two 18-day long flights of its solar-powered aircraft, named Zephyr; William Davies, Associate Analyst at GlobalData, a leading data and analytics company, offers his view: “In recent years there has been increasing pressure to pursue sustainable aviation solutions, with companies in the aerospace sector currently facing political and […]
Read more

Immuno-Oncology the most transformative treatment since chemotherapy is set to benefit more patients

Immuno-oncology (IO) agents, particularly immune checkpoint inhibitors (ICIs) and CAR-T cell therapies, have extended the survival of patients in many cancer types and current investigational approaches in the industry and academia will lead to even further clinical improvement, says GlobalData, a leading data and analytics company. The company’s latest report, ‘Immuno-Oncology – Market Analysis, Trends, […]
Read more
1 2 3 4